Have any questions ?   fmliu@czbiowin.com          907264584@qq.com  
  HOME ABOUT PRODUCTS SUPPORT OEM COVID19 CONTACT


  ¡ö  COVID-19
  ¡ö  Monkeypox virus
  ¡ö  Human Papillomavirus
  ¡ö  Plasmodium falciparum
  ¡ö  Helicobacter pylori
  ¡ö  Cardiovascular disease
  ¡ö  Kidney disease
  ¡ö  Prostate disease
  ¡ö  Drug testing
  ¡ö  Sampling class

COVID-19 Nucleic Acid Test

Specifications:

Intended Use

This product is used for the qualitative detection of SARS-CoV-2 (COVID-19) the S and Ngenes in the throat swab and sputum sample. This kit is applicable to qualitatively test of the novel coronavirus(COVID-19,also known as SARS-CoV-2) in a suspected case of pneumonia infected with a Novel Coronavirus,a suspected case of a cluster,other patients who need to be diagnosed with a novel coronavirus infectin or differential diagnosis.

 

Principle

This kit uses One-Step Real-Time PCR and TaqMan-MGB fluorescent probe technology. Primers and probes are designed in the highly conserved regions of the S and N gene sequences of COVID-19, and human RNase P gene as internal control. This kit has been validated on samples extracted from sputum, nasopharyngeal and throat swabs. Three fluorescent reporters are incorporated into this test: FAM measures the COVID-19 S gene; VIC measures the COVID-19 N gene; CY5 measures human RNase P gene as internal control.

 

Sample requirements

The nucleic acids extraction in throat swabs or and sputum sample from individual suspected of COVID-19 infection by their health provider is required for the detection. Specimen collection should avoid possible contamination in collection, storage, and transportation. Samples can be inactivated at 56¡æ for 30 minutes. Following extraction, RNA samples should be used immediately or stored at -70¡ãC for use later. Avoid and minimize repeated sample freezing and thawing.

 

Performance Characteristics

Analytical sensitivity (limit of detection) is defined as the lowest concentration at which the detection rate of at least 95% for 20 samples. The analytical sensitivity of the assay was determined by analyzing a dilution series of in vitro transcribe (Pseudovirus) RNA from 20 to 500 copies/mL for S gene and N gene. The testing was carried out in either 5-replicates (for concentrations¡Ý200 copies/mL) or 10-replicates (for concentrations<200 copies/mL).

 

Storage and validity

The kit reagents should be stored at -20¡À10¡æ in the dark in a freezer. When properly stored, the reagents are stable for 12 months when sealed and 2 months after initial use. Avoid and reduce repeated freezing and thawing. The reagents should be discarded after 5 times of freezing and thawing. If reagents will be used intermittently, it is suggested to keep the reagents frozen in aliquots.





 
  +86 519 85519908
  fmliu@czbiowin.com
  907264584@qq.com
  California Science and Technology Port, 218 Fumin Road, Changzhou City
OUR PRODUCT
 
COVID-19
Monkeypox virus
Human Papillomavirus
Plasmodium falciparum
Helicobacter pylori
Cardiovascular disease
Kidney disease
Prostate disease
Drug testing
Sampling class
NEWS
 
Covid-19 topic
Company news
Download Center
ABOUT US
 
Contact
Our Culture
Company Profile
Certifications


 
© 2020 Changzhou Biowin Pharmaceutical Co., Ltd. All rights reserved.    ËÕICP±¸2020060598ºÅ-1